
Michael Hofman/X
Apr 27, 2025, 12:09
Michael Hofman: New Frontiers in PSMA Radioligand Therapy
Michael Hofman, Director of Prostate Cancer Theranostics and Imaging Centre of Excellence (ProSTIC) at Peter MacCallum Cancer Centre, shared a post on X:
“New Frontiers in PSMA Radioligand Therapy
Is this the ‘hottest’ session at ASCO25 ??
VIOLET: First-in-human trial of Terbium-161
BULLSEYE: Lu-PSMA in oligo-metastatic disease
ENZA-p: Biomarkers
More posts featuring ASCO25.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 27, 2025, 12:09
Apr 27, 2025, 11:20
Apr 27, 2025, 11:06